Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection...
Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Direct-acting anti-viral agents have improved the treatment of chronic hepatitis C virus (HCV) infection, but this treatment is challenging for patients using co-medications because of potential drug-drug interactions. This study aimed to examine the comorbidities and co-medications of Japanese chronic HCV patients by age group, compared with a non...
Alternative Titles
Full title
Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d266371912ad4a4db3c5fb80bd194039
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d266371912ad4a4db3c5fb80bd194039
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-018-3148-z
